Research Progress of Tirofiban Combined with Mechanical Thrombectomy in the Treatment of Acute Ischemic Stroke

doi:10.3969/j.issn.1673-5765.2024.05.013

Abstract

Abstract: In acute ischemic stroke patients with large vessel occlusion, mechanical thrombectomy can improve the hemodynamic status and clinical symptoms within the effective time, but mechanical thrombectomy is often associated with vascular re-occlusion, which affects the prognosis of patients. Platelet glycoprotein Ⅱb/Ⅲa (GP Ⅱb/Ⅲa) receptor antagonists prevent vascular re-occlusion by inhibiting the last common pathway of platelet aggregation. At present, the effects of GP Ⅱb/Ⅲa receptor antagonists on the clinical outcome during the perioperative period of mechanical thrombectomy in ischemic stroke remain controversial. This paper reviewd the efficacy and safety of tirofiban, a GP Ⅱb/Ⅲa receptor antagonist, in the treatment of vascular re-occlusion after mechanical thrombectomy in acute ischemic stroke. It was found that tirofiban combined with mechanical thrombectomy was safe for the treatment of acute ischemic stroke, but its therapeutic effectiveness still needs to be confirmed by standardized clinical research evidence.

Key words: Acute ischemic stroke; Mechanical thrombectomy; Tirofiban; Efficacy; Safety

摘要： 急性缺血性卒中大血管闭塞患者在有效时间内经机械取栓治疗可改善血流动力学状态及临床症状，但机械取栓常合并血管再闭塞，影响患者预后。血小板糖蛋白Ⅱb/Ⅲa（platelet glycoprotein Ⅱb/Ⅲa，GP Ⅱb/Ⅲa）受体拮抗剂通过抑制血小板聚集过程的最后共同通路防止血管再闭塞。目前，在缺血性卒中机械取栓治疗的围手术期，辅以GP Ⅱb/Ⅲa受体拮抗剂治疗对临床结局的影响尚存争议。本文对GP Ⅱb/Ⅲa受体拮抗剂替罗非班对急性缺血性卒中机械取栓后血管再闭塞的疗效及安全性进行综述，发现替罗非班联合机械取栓治疗急性缺血性卒中是安全的，但有效性尚需要规范的临床研究证据证实。

关键词: 急性缺血性卒中; 机械取栓; 替罗非班; 有效性; 安全性

CLC Number:

ZHENG Guomin, LIANG Zhigang, ZHANG Zhen. Research Progress of Tirofiban Combined with Mechanical Thrombectomy in the Treatment of Acute Ischemic Stroke[J]. Chinese Journal of Stroke, 2024, 19(5): 573-578.

郑国民, 梁志刚, 张振. 替罗非班联合机械取栓治疗急性缺血性卒中的研究进展[J]. 中国卒中杂志, 2024, 19(5): 573-578.

References

[1] 霍晓川，高峰. 急性缺血性卒中血管内治疗中国指南2023[J]. 中国卒中杂志，2023，18（6）：684-711.
HUO X C，GAO F. Chinese guidelines for endovascular treatment of acute ischemic stroke 2023[J]. Chin J Stroke，2023，18（6）：684-711.
[2] 李莉，赵鑫，班茹，等. 急性大血管闭塞性脑卒中血管内治疗的研究进展[J]. 中华老年心脑血管病杂志，2020，22（5）：553-555.
LI L，ZHAO X，BAN R，et al. Research progress of endovascular therapy for acute large vascular occlusive stroke[J]. Chinese Journal of Geriatric Heart Brain and Vessel Diseases，2020，22（5）：553-555.
[3] TENG D，PANNELL J S，RENNERT R C，et al. Endothelial trauma from mechanical thrombectomy in acute stroke：in vitro live-cell platform with animal validation[J]. Stroke，2015，46（4）：1099-1106.
[4] HEO J H，LEE K Y，KIM S H，et al. Immediate reocclusion following a successful thrombolysis in acute stroke：a pilot study[J]. Neurology，2003，60（10）：1684-1687.
[5] SHATTIL S J，NEWMAN P J. Integrins：dynamic scaffolds for adhesion and signaling in platelets[J]. Blood，2004，104（6）：1606-1615.
[6] MURUGAPPAN S，SHANKAR H，KUNAPULI S P. Platelet receptors for adenine nucleotides and thromboxane A2[J]. Semin Thromb Hemost，2004，30（4）：411-418.
[7] 中国卒中学会，中国卒中学会神经介入分会，中华预防医学会卒中预防与控制专业委员会介入学组. 替罗非班在动脉粥样硬化性脑血管疾病中的临床应用专家共识[J]. 中国卒中杂志，2019，14（10）：1034-1044.
Chinese Stroke Association，Chinese Interventional Neuroradiology Society，Intervention Group of Committee of Stroke Prevention and Control of Chinese Preventive Medicine Association. Chinese experts consensus on clinical application of tirofiban in atherosclerotic cerebrovascular diseases[J]. Chin J Stroke，2019，14（10）：1034-1044.
[8] KING S，SHORT M，HARMON C. Glycoprotein Ⅱb/Ⅲa inhibitors：the resurgence of tirofiban[J/OL]. Vascul Pharmacol，2016，78：10-16[2023-06-11]. https://doi.org/10.1016/j.vph.2015.07.008.
[9] 刘晓丽，彭萍安，程宇婧. 血小板糖蛋白Ⅱb/Ⅲa受体拮抗剂在冠状动脉粥样硬化性心脏病治疗的中国专家共识（2016）[J]. 心肺血管病杂志，2016，35（12）：923-932.
LIU X L，PENG P A，CHENG Y J. Chinese expert consensus on platelet glycoprotein Ⅱb/Ⅲa receptor antagonists in the treatment of coronary atherosclerotic heart disease（2016）[J]. Journal of Cardiovascular and Pulmonary Diseases，2016，35（12）：923-932.
[10] 替罗非班治疗冠状动脉粥样硬化性心脏病专家共识组. 替罗非班在冠状动脉粥样硬化性心脏病治疗的中国专家共识[J]. 中华内科杂志，2013，52（5）：434-439.
Expert Consensus Group on Tirofiban in the Treatment of Coronary Atherosclerotic Heart Disease. Chinese expert consensus on tirofiban in the treatment of coronary atherosclerotic heart disease[J]. Chin J Intern Med，2013，52（5）：434-439.
[11] ZHANG Y，ZHANG Q Q，FU C，et al. Clinical efficacy of tirofiban combined with a Solitaire stent in treating acute ischemic stroke[J/OL]. Braz J Med Biol Res，2019，52（10）：e8396[2023-06-11]. https://doi.org/10.1590/1414-431X20198396.
[12] LUO Y，YANG Y，XIE Y，et al. Therapeutic effect of pre-operative tirofiban on patients with acute ischemic stroke with mechanical thrombectomy within 6-24 hours[J]. Interv Neuroradiol，2019，25（6）：705-709.
[13] QIU Z M，LI F L，SANG H F，et al. Effect of intravenous tirofiban vs. placebo before endovascular thrombectomy on functional outcomes in large vessel occlusion stroke：the RESCUE BT randomized clinical trial[J]. JAMA，2022，328（6）：543-553.
[14] ZHANG S，HAO Y G，TIAN X G，et al. Safety of intra-arterial tirofiban administration in ischemic stroke patients after unsuccessful mechanical thrombectomy[J]. J Vasc Interv Radiol，2019，30（2）：141-147.
[15] KANG D H，YOON W，KIM S K，et al. Endovascular treatment for emergent large vessel occlusion due to severe intracranial atherosclerotic stenosis[J]. J Neurosurg，2019，130（6）：1949-1956.
[16] YU T Y，LIN Y Y，JIN A P，et al. Safety and efficiency of low dose intra-arterial tirofiban in mechanical thrombectomy during acute ischemic stroke[J]. Curr Neurovasc Res，2018，15（2）：145-150.
[17] SUN C，LI X，ZHAO Z，et al. Safety and efficacy of tirofiban combined with mechanical thrombectomy depend on ischemic stroke etiology[J/OL]. Front Neurol，2019，10：1100[2023-06-11]. https://doi.org/10.3389/fneur.2019.01100.
[18] YI H J，SUNG J H，LEE D H. Safety and efficacy of intra-arterial tirofiban injection during mechanical thrombectomy for large artery occlusion[J]. Curr Neurovasc Res，2019，16（5）：416-424.
[19] ZHAO L，JIAN Y，LI T，et al. The safety and efficiency of tirofiban in acute ischemic stroke patients treated with mechanical thrombectomy：a multicenter retrospective cohort study[J/OL]. Biochem Res Int，2020，2020：5656173[2023-06-11]. https://doi.org/10.1155/2020/5656173.
[20] HUO X C，YANG M，MA N，et al. Safety and efficacy of tirofiban during mechanical thrombectomy for stroke patients with preceding intravenous thrombolysis[J/OL]. Clin Interv Aging，2020，15：1241-1248[2023-06-11]. https://doi.org/10.2147/CIA.S238769.
[21] HUO X C，RAYNALD，WANG A X，et al. Safety and efficacy of tirofiban for acute ischemic stroke patients with large artery atherosclerosis stroke etiology undergoing endovascular therapy[J/OL]. Front Neurol，2021，12：630301[2023-06-11]. https://doi.org/10.3389/fneur.2021.630301.
[22] YANG M，HUO X，GAO F，et al. Low-dose rescue tirofiban in mechanical thrombectomy for acute cerebral large-artery occlusion[J]. Eur J Neurol，2020，27（6）：1056-1061.
[23] ZHAO W B，CHE R W，SHANG S Y，et al. Low-dose tirofiban improves functional outcome in acute ischemic stroke patients treated with endovascular thrombectomy[J]. Stroke，2017，48（12）：3289-3294.
[24] PAN X D，XU M Y，FEI Y X，et al. Influence of tirofiban on stroke outcome after mechanical thrombectomy in acute vertebrobasilar artery occlusion[J/OL]. BMC Neurol，2022，22（1）：460[2023-06-11]. https://doi.org/10.1186/s12883-022-02996-5.
[25] CHENG Z，GENG X K，GAO J，et al. Intravenous administration of standard dose tirofiban after mechanical arterial recanalization is safe and relatively effective in acute ischemic stroke[J]. Aging Dis，2019，10（5）：1049-1057.
[26] ZHONG H L，ZHOU T F，HE Y K，et al. Safety and efficacy of adjunct tirofiban treatment following mechanical thrombectomy for acute ischemic stroke patients with large vessel occlusion（LVO）resulting in successful reperfusion[J/OL]. Interv Neuroradiol，2022：15910199221138883[2023-06-11]. https://doi.org/10.1177/15910199221138883.
[27] PAN X，ZHENG D，ZHENG Y，et al. Safety and efficacy of tirofiban combined with endovascular treatment in acute ischaemic stroke[J]. Eur J Neurol，2019，6（8）：1105-1110.
[28] CHEN Q，MENG R L，WU D P，et al. Association of intravenous tirofiban with functional outcomes in acute ischemic stroke patients with acute basilar artery occlusion receiving endovascular thrombectomy[J]. Cerebrovasc Dis，2023，52（4）：451-459.